Acute, periprocedural and longterm antithrombotic therapy in older adults

Bibliographic Details
Main Author: Andreotti, Felicita
Publication Date: 2023
Other Authors: Geisler, Tobias, Collet, Jean-Philippe, Gigante, Bruna, Gorog, Diana A, Halvorsen, Sigrun, Lip, Gregory Y H, Morais, João, Navarese, Eliano Pio, Patrono, Carlo, Rocca, Bianca, Rubboli, Andrea, Sibbing, Dirk, Storey, Robert F, Verheugt, Freek W A, Vilahur, Gemma
Format: Article
Language: eng
Source: Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
Download full: http://hdl.handle.net/10400.8/9106
Summary: The first international guidance on antithrombotic therapy in the elderly came from the European Society of Cardiology Working Group on Thrombosis in 2015. This same group has updated its previous report on antiplatelet and anticoagulant drugs for older patients with acute or chronic coronary syndromes, atrial fibrillation, or undergoing surgery or procedures typical of the elderly (transcatheter aortic valve implantation and left atrial appendage closure). The aim is to provide a succinct but comprehensive tool for readers to understand the bases of antithrombotic therapy in older patients, despite the complexities of comorbidities, comedications and uncertain ischaemic- vs. bleeding-risk balance. Fourteen updated consensus statements integrate recent trial data and other evidence, with a focus on high bleeding risk. Guideline recommendations, when present, are highlighted, as well as gaps in evidence. Key consensus points include efforts to improve medical adherence through deprescribing and polypill use; adoption of universal risk definitions for bleeding, myocardial infarction, stroke and cause-specific death; multiple bleeding-avoidance strategies, ranging from gastroprotection with aspirin use to selection of antithrombotic-drug composition, dosing and duration tailored to multiple variables (setting, history, overall risk, age, weight, renal function, comedications, procedures) that need special consideration when managing older adults. © The Author(s) 2022. Published by Oxford University Press on behalf of European Society of Cardiology. All rights reserved.
id RCAP_6408db662aaf0b8f7149b88b3a3b70a3
oai_identifier_str oai:iconline.ipleiria.pt:10400.8/9106
network_acronym_str RCAP
network_name_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository_id_str https://opendoar.ac.uk/repository/7160
spelling Acute, periprocedural and longterm antithrombotic therapy in older adultsElderlyAntiplateletAnticoagulantCoronary syndromesAtrial fibrillationSurgeryTAVILAACThe first international guidance on antithrombotic therapy in the elderly came from the European Society of Cardiology Working Group on Thrombosis in 2015. This same group has updated its previous report on antiplatelet and anticoagulant drugs for older patients with acute or chronic coronary syndromes, atrial fibrillation, or undergoing surgery or procedures typical of the elderly (transcatheter aortic valve implantation and left atrial appendage closure). The aim is to provide a succinct but comprehensive tool for readers to understand the bases of antithrombotic therapy in older patients, despite the complexities of comorbidities, comedications and uncertain ischaemic- vs. bleeding-risk balance. Fourteen updated consensus statements integrate recent trial data and other evidence, with a focus on high bleeding risk. Guideline recommendations, when present, are highlighted, as well as gaps in evidence. Key consensus points include efforts to improve medical adherence through deprescribing and polypill use; adoption of universal risk definitions for bleeding, myocardial infarction, stroke and cause-specific death; multiple bleeding-avoidance strategies, ranging from gastroprotection with aspirin use to selection of antithrombotic-drug composition, dosing and duration tailored to multiple variables (setting, history, overall risk, age, weight, renal function, comedications, procedures) that need special consideration when managing older adults. © The Author(s) 2022. Published by Oxford University Press on behalf of European Society of Cardiology. All rights reserved.Oxford University Press; European Society of CardiologyRepositório IC-OnlineAndreotti, FelicitaGeisler, TobiasCollet, Jean-PhilippeGigante, BrunaGorog, Diana AHalvorsen, SigrunLip, Gregory Y HMorais, JoãoNavarese, Eliano PioPatrono, CarloRocca, BiancaRubboli, AndreaSibbing, DirkStorey, Robert FVerheugt, Freek W AVilahur, Gemma2023-12-18T17:59:00Z2023-01-212023-01-21T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.8/9106eng0195-668Xhttps://doi.org/10.1093/eurheartj/ehac515info:eu-repo/semantics/openAccessreponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAP2025-02-25T15:14:57Zoai:iconline.ipleiria.pt:10400.8/9106Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-28T20:54:05.834112Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse
dc.title.none.fl_str_mv Acute, periprocedural and longterm antithrombotic therapy in older adults
title Acute, periprocedural and longterm antithrombotic therapy in older adults
spellingShingle Acute, periprocedural and longterm antithrombotic therapy in older adults
Andreotti, Felicita
Elderly
Antiplatelet
Anticoagulant
Coronary syndromes
Atrial fibrillation
Surgery
TAVI
LAAC
title_short Acute, periprocedural and longterm antithrombotic therapy in older adults
title_full Acute, periprocedural and longterm antithrombotic therapy in older adults
title_fullStr Acute, periprocedural and longterm antithrombotic therapy in older adults
title_full_unstemmed Acute, periprocedural and longterm antithrombotic therapy in older adults
title_sort Acute, periprocedural and longterm antithrombotic therapy in older adults
author Andreotti, Felicita
author_facet Andreotti, Felicita
Geisler, Tobias
Collet, Jean-Philippe
Gigante, Bruna
Gorog, Diana A
Halvorsen, Sigrun
Lip, Gregory Y H
Morais, João
Navarese, Eliano Pio
Patrono, Carlo
Rocca, Bianca
Rubboli, Andrea
Sibbing, Dirk
Storey, Robert F
Verheugt, Freek W A
Vilahur, Gemma
author_role author
author2 Geisler, Tobias
Collet, Jean-Philippe
Gigante, Bruna
Gorog, Diana A
Halvorsen, Sigrun
Lip, Gregory Y H
Morais, João
Navarese, Eliano Pio
Patrono, Carlo
Rocca, Bianca
Rubboli, Andrea
Sibbing, Dirk
Storey, Robert F
Verheugt, Freek W A
Vilahur, Gemma
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Repositório IC-Online
dc.contributor.author.fl_str_mv Andreotti, Felicita
Geisler, Tobias
Collet, Jean-Philippe
Gigante, Bruna
Gorog, Diana A
Halvorsen, Sigrun
Lip, Gregory Y H
Morais, João
Navarese, Eliano Pio
Patrono, Carlo
Rocca, Bianca
Rubboli, Andrea
Sibbing, Dirk
Storey, Robert F
Verheugt, Freek W A
Vilahur, Gemma
dc.subject.por.fl_str_mv Elderly
Antiplatelet
Anticoagulant
Coronary syndromes
Atrial fibrillation
Surgery
TAVI
LAAC
topic Elderly
Antiplatelet
Anticoagulant
Coronary syndromes
Atrial fibrillation
Surgery
TAVI
LAAC
description The first international guidance on antithrombotic therapy in the elderly came from the European Society of Cardiology Working Group on Thrombosis in 2015. This same group has updated its previous report on antiplatelet and anticoagulant drugs for older patients with acute or chronic coronary syndromes, atrial fibrillation, or undergoing surgery or procedures typical of the elderly (transcatheter aortic valve implantation and left atrial appendage closure). The aim is to provide a succinct but comprehensive tool for readers to understand the bases of antithrombotic therapy in older patients, despite the complexities of comorbidities, comedications and uncertain ischaemic- vs. bleeding-risk balance. Fourteen updated consensus statements integrate recent trial data and other evidence, with a focus on high bleeding risk. Guideline recommendations, when present, are highlighted, as well as gaps in evidence. Key consensus points include efforts to improve medical adherence through deprescribing and polypill use; adoption of universal risk definitions for bleeding, myocardial infarction, stroke and cause-specific death; multiple bleeding-avoidance strategies, ranging from gastroprotection with aspirin use to selection of antithrombotic-drug composition, dosing and duration tailored to multiple variables (setting, history, overall risk, age, weight, renal function, comedications, procedures) that need special consideration when managing older adults. © The Author(s) 2022. Published by Oxford University Press on behalf of European Society of Cardiology. All rights reserved.
publishDate 2023
dc.date.none.fl_str_mv 2023-12-18T17:59:00Z
2023-01-21
2023-01-21T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.8/9106
url http://hdl.handle.net/10400.8/9106
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 0195-668X
https://doi.org/10.1093/eurheartj/ehac515
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Oxford University Press; European Society of Cardiology
publisher.none.fl_str_mv Oxford University Press; European Society of Cardiology
dc.source.none.fl_str_mv reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron:RCAAP
instname_str FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron_str RCAAP
institution RCAAP
reponame_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
collection Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository.name.fl_str_mv Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
repository.mail.fl_str_mv info@rcaap.pt
_version_ 1833598944385433600